1. Uncategorized

Uterine Manipulation Devices Market (2022-2030) Growth Rate Pricing And Industry Forecast 

Uterine Manipulation Devices Industry Overview

The global uterine manipulation devices market size is expected to reach USD 373.81 million by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.6% from 2021 to 2028. A surge in the prevalence of gynecological diseases, coupled with the rising preference for minimally invasive surgical procedures, is a key driving factor for the market.

Uterine Manipulation Devices Market Segmentation

Grand View Research has segmented the global uterine manipulation devices market on the basis of application, end-use, and region:

Based on the Application Insights, the market is segmented into Total Laparoscopy Hysterectomy (TLH), Laparoscopic Supracervical Hysterectomy (LSH), Laparoscopically Assisted Vaginal Hysterectomy (LAVH), Sacrocolpopexy, Other Applications.

  • In 2020, the total laparoscopic hysterectomy (TLH) segment dominated the market with a revenue share of 38.88%. TLH is performed for treating conditions such as fibroids, pelvic pain, painful or heavy menstrual periods, pre-cancer or cancer in the uterus, endometriosis or adenomyosis, or prolapse.
  • Moreover, the recovery period associated with major abdominal hysterectomy is longer in comparison with laparoscopic surgery, which is leading to an increase in the preference for laparoscopic surgery.
  • The laparoscopic supracervical hysterectomy (LSH) segment is expected to expand at the highest CAGR during the forecast period. A laparoscopic supracervical hysterectomy (LSH) is also a minimally invasive procedure, which involves removing a uterus and leaving the cervix in place.
  • LSH is a partial hysterectomy that removes only the diseased uterus and preserves the cervix, and often ovaries, thus resulting in less pain, fewer adhesions, less technical difficulty, and quicker recovery than open surgery.

Based on the End-use Insights, the market is segmented into Hospitals, Clinics, Ambulatory Surgery Centers (ASCs).

  • In 2020, the hospitals segment dominated the market with a share of 59.15%. The growth of this segment can mainly be attributed to an increase in the number of patients suffering from various gynecological conditions and a consequent rise in the number of surgical procedures.
  • Hospitals offer superior care to patients and provide reimbursements for certain procedures, which is further contributing to the segment growth. Furthermore, hospitals are currently advancing in terms of technology. Technologically advanced devices are being used extensively in hospitals to provide better treatment. 
  • The ambulatory surgery centers segment is expected to expand at the highest CAGR during the forecast period. High preference for outpatient surgeries, increase in the adoption of minimally invasive surgeries, and cost-effectiveness of ambulatory surgery center-based laparoscopic procedures are among the key factors responsible for the lucrative growth of this segment.
  • Most intra-abdominal procedures can now be performed laparoscopically at ambulatory surgery centers as these are less invasive. Surgeries at ambulatory surgery centers not only have shorter stay duration but are also more affordable than inpatient procedures, which reduces patient expenditure.

Uterine Manipulation Devices Regional Outlook 

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA)

Key Companies Profile & Market Share Insights

Key players are involved in adopting strategies such as mergers & acquisitions, partnerships, and new product launches to strengthen their foothold in the market.

Some prominent players in the global uterine manipulation devices market include

  • Conkin Surgical Instruments Ltd.
  • Johnson and Johnson
  • CooperSurgical, Inc.
  • B. Braun Medical Ltd.
  • KARL STORZ GmbH & Co. KG
  • CONMED Corporation
  • RUDOLF Medical GmbH + Co. KG
  • LiNA Medical ApS
  • Richard Wolf GmbH
  • Utah Medical Products, Inc.
  • Purple Surgical
  • Clinical Innovations, LLC
  • Bissinger Medizintechnik
  • The O.R. Company (Symmetry Surgical Inc.)
  • LSI Solutions, Inc.

Order a free sample PDF of the Uterine Manipulation Devices Market Intelligence Study, published by Grand View Research. 

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: [email protected]

Web: https://www.grandviewresearch.com

Follow Us: LinkedIn | Twitter

Uterine Manipulation Devices Industry Overview

The global uterine manipulation devices market size is expected to reach USD 373.81 million by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.6% from 2021 to 2028. A surge in the prevalence of gynecological diseases, coupled with the rising preference for minimally invasive surgical procedures, is a key driving factor for the market.

Uterine Manipulation Devices Market Segmentation

Grand View Research has segmented the global uterine manipulation devices market on the basis of application, end-use, and region:

Based on the Application Insights, the market is segmented into Total Laparoscopy Hysterectomy (TLH), Laparoscopic Supracervical Hysterectomy (LSH), Laparoscopically Assisted Vaginal Hysterectomy (LAVH), Sacrocolpopexy, Other Applications.

  • In 2020, the total laparoscopic hysterectomy (TLH) segment dominated the market with a revenue share of 38.88%. TLH is performed for treating conditions such as fibroids, pelvic pain, painful or heavy menstrual periods, pre-cancer or cancer in the uterus, endometriosis or adenomyosis, or prolapse.
  • Moreover, the recovery period associated with major abdominal hysterectomy is longer in comparison with laparoscopic surgery, which is leading to an increase in the preference for laparoscopic surgery.
  • The laparoscopic supracervical hysterectomy (LSH) segment is expected to expand at the highest CAGR during the forecast period. A laparoscopic supracervical hysterectomy (LSH) is also a minimally invasive procedure, which involves removing a uterus and leaving the cervix in place.
  • LSH is a partial hysterectomy that removes only the diseased uterus and preserves the cervix, and often ovaries, thus resulting in less pain, fewer adhesions, less technical difficulty, and quicker recovery than open surgery.

Based on the End-use Insights, the market is segmented into Hospitals, Clinics, Ambulatory Surgery Centers (ASCs).

  • In 2020, the hospitals segment dominated the market with a share of 59.15%. The growth of this segment can mainly be attributed to an increase in the number of patients suffering from various gynecological conditions and a consequent rise in the number of surgical procedures.
  • Hospitals offer superior care to patients and provide reimbursements for certain procedures, which is further contributing to the segment growth. Furthermore, hospitals are currently advancing in terms of technology. Technologically advanced devices are being used extensively in hospitals to provide better treatment. 
  • The ambulatory surgery centers segment is expected to expand at the highest CAGR during the forecast period. High preference for outpatient surgeries, increase in the adoption of minimally invasive surgeries, and cost-effectiveness of ambulatory surgery center-based laparoscopic procedures are among the key factors responsible for the lucrative growth of this segment.
  • Most intra-abdominal procedures can now be performed laparoscopically at ambulatory surgery centers as these are less invasive. Surgeries at ambulatory surgery centers not only have shorter stay duration but are also more affordable than inpatient procedures, which reduces patient expenditure.

Uterine Manipulation Devices Regional Outlook 

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA)

Key Companies Profile & Market Share Insights

Key players are involved in adopting strategies such as mergers & acquisitions, partnerships, and new product launches to strengthen their foothold in the market.

Some prominent players in the global uterine manipulation devices market include

  • Conkin Surgical Instruments Ltd.
  • Johnson and Johnson
  • CooperSurgical, Inc.
  • B. Braun Medical Ltd.
  • KARL STORZ GmbH & Co. KG
  • CONMED Corporation
  • RUDOLF Medical GmbH + Co. KG
  • LiNA Medical ApS
  • Richard Wolf GmbH
  • Utah Medical Products, Inc.
  • Purple Surgical
  • Clinical Innovations, LLC
  • Bissinger Medizintechnik
  • The O.R. Company (Symmetry Surgical Inc.)
  • LSI Solutions, Inc.

Order a free sample PDF of the Uterine Manipulation Devices Market Intelligence Study, published by Grand View Research. 

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: [email protected]

Web: https://www.grandviewresearch.com

Follow Us: LinkedIn | Twitter

Uterine Manipulation Devices Industry Overview

The global uterine manipulation devices market size is expected to reach USD 373.81 million by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.6% from 2021 to 2028. A surge in the prevalence of gynecological diseases, coupled with the rising preference for minimally invasive surgical procedures, is a key driving factor for the market.

Uterine Manipulation Devices Market Segmentation

Grand View Research has segmented the global uterine manipulation devices market on the basis of application, end-use, and region:

Based on the Application Insights, the market is segmented into Total Laparoscopy Hysterectomy (TLH), Laparoscopic Supracervical Hysterectomy (LSH), Laparoscopically Assisted Vaginal Hysterectomy (LAVH), Sacrocolpopexy, Other Applications.

  • In 2020, the total laparoscopic hysterectomy (TLH) segment dominated the market with a revenue share of 38.88%. TLH is performed for treating conditions such as fibroids, pelvic pain, painful or heavy menstrual periods, pre-cancer or cancer in the uterus, endometriosis or adenomyosis, or prolapse.
  • Moreover, the recovery period associated with major abdominal hysterectomy is longer in comparison with laparoscopic surgery, which is leading to an increase in the preference for laparoscopic surgery.
  • The laparoscopic supracervical hysterectomy (LSH) segment is expected to expand at the highest CAGR during the forecast period. A laparoscopic supracervical hysterectomy (LSH) is also a minimally invasive procedure, which involves removing a uterus and leaving the cervix in place.
  • LSH is a partial hysterectomy that removes only the diseased uterus and preserves the cervix, and often ovaries, thus resulting in less pain, fewer adhesions, less technical difficulty, and quicker recovery than open surgery.

Based on the End-use Insights, the market is segmented into Hospitals, Clinics, Ambulatory Surgery Centers (ASCs).

  • In 2020, the hospitals segment dominated the market with a share of 59.15%. The growth of this segment can mainly be attributed to an increase in the number of patients suffering from various gynecological conditions and a consequent rise in the number of surgical procedures.
  • Hospitals offer superior care to patients and provide reimbursements for certain procedures, which is further contributing to the segment growth. Furthermore, hospitals are currently advancing in terms of technology. Technologically advanced devices are being used extensively in hospitals to provide better treatment. 
  • The ambulatory surgery centers segment is expected to expand at the highest CAGR during the forecast period. High preference for outpatient surgeries, increase in the adoption of minimally invasive surgeries, and cost-effectiveness of ambulatory surgery center-based laparoscopic procedures are among the key factors responsible for the lucrative growth of this segment.
  • Most intra-abdominal procedures can now be performed laparoscopically at ambulatory surgery centers as these are less invasive. Surgeries at ambulatory surgery centers not only have shorter stay duration but are also more affordable than inpatient procedures, which reduces patient expenditure.

Uterine Manipulation Devices Regional Outlook 

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA)

Key Companies Profile & Market Share Insights

Key players are involved in adopting strategies such as mergers & acquisitions, partnerships, and new product launches to strengthen their foothold in the market.

Some prominent players in the global uterine manipulation devices market include

  • Conkin Surgical Instruments Ltd.
  • Johnson and Johnson
  • CooperSurgical, Inc.
  • B. Braun Medical Ltd.
  • KARL STORZ GmbH & Co. KG
  • CONMED Corporation
  • RUDOLF Medical GmbH + Co. KG
  • LiNA Medical ApS
  • Richard Wolf GmbH
  • Utah Medical Products, Inc.
  • Purple Surgical
  • Clinical Innovations, LLC
  • Bissinger Medizintechnik
  • The O.R. Company (Symmetry Surgical Inc.)
  • LSI Solutions, Inc.

Order a free sample PDF of the Uterine Manipulation Devices Market Intelligence Study, published by Grand View Research. 

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: [email protected]

Web: https://www.grandviewresearch.com

Follow Us: LinkedIn | Twitter

Comments to: